Navigation Links
Isis Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference

CARLSBAD, Calif., March 2 /PRNewswire-FirstCall/ --Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Cowen's 30th Annual Health Care Conference on Monday, March 8, 2010 at 2:30 p.m. ET at The Boston Marriott Copley Place.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site,  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.


Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners.  The Company has successfully commercialized the world's first antisense drug and has 22 drugs in development.  Isis' drug development programs are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide.  Additional information about Isis is available at

SOURCE Isis Pharmaceuticals, Inc.

Back to top



SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
2. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
3. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
4. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
5. Ferring Pharmaceuticals and Gene Security Network Partner to Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
6. Pharmaceutical Industry Veteran is Appointed CMO at Kinex Pharmaceuticals
7. Kinex Pharmaceuticals Initiates a Phase 2 Clinical Trial of KX2-391 in Patients with Prostate Cancer
8. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
9. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
10. Jazz Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 3, 2010
11. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
Post Your Comments:
(Date:11/30/2015)... CHICAGO , Dec. 1, 2015 Researchers ... that measures body part thickness and checks for motion, ... to a feasibility study presented today at the annual ... America (RSNA). Steven Don , ... Radiology, Washington University School of Medicine in ...
(Date:11/30/2015)... Express Scripts (NASDAQ: ESRX ) today announced it will ... access to a low-cost alternative to Daraprim (pyrimethamine) , ... recently priced out of reach for people with HIV, pregnant ... --> --> Imprimis is offering a compounded ... acid) for $1 per capsule for people whose pharmacy benefit is ...
(Date:11/30/2015)... décembre 2015 MEDTEC Japon ... conférence d,Asie portant sur la conception ... manufacturière, se tiendra à ... 22 avril 2016. ... Photo - Logo ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... December 01, 2015 , ... The National Association ... inductee into its VIP Woman of the Year Circle. She is recognized with ... organization exclusively for professional women, boasting 850,000 members and over 200 operating Local ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well ... vision insurance plans on . The multi-carrier insurance exchange platform offers ... products, allowing consumers to compare, quote and match plans to meet their needs. ...
(Date:11/30/2015)... ... November 30, 2015 , ... Stress, anxiety, illness, infection or ... worry about possible tumors? , Heather Spader, MD, a new pediatric neurosurgeon at Joe ... some signs might point to tumors. , “Bad headaches that don’t go ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... MOSI recently ... and Sea along with Back to the Jurassic to their collection of interactive exhibits ... has created dynamic worlds that will allow guests to get closer than ever to ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... On Saturday, ... American Cancer Society held an annual fundraising event, a 5K walk known as “Making ... treatment center for substance abuse which is also located in Battle Creek, joined in ...
Breaking Medicine News(10 mins):